What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 - The Lancet Infectious Diseases
A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines | NEJM
VERIFY: Why is absolute risk reduction in COVID-19 vaccines smaller than relative risk reduction? - YouTube
Efficacy of a Cell-Culture–Derived Quadrivalent Influenza Vaccine in Children | NEJM
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression - The Lancet
Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50 | Nature Communications
PolitiFact | Instagram post misleads on vaccine efficacy by conflating two different measures
Absolute risk reduction formula vs. Relative risk reduction | wusa9.com
Pfizer Vaccine Efficacy Explained - Coronavirus News - YouTube
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM
Medicina | Free Full-Text | Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine | NEJM
![Polio Eradication or Comeback? Outcome Reporting Bias in the 1954 Poliomyelitis Vaccine Field Trial[v1] | Preprints.org](https://www.preprints.org/img/dyn_abstract_figures/2022/09/349a81de2b88fc415a7957a492e17d80/graphical.v1.png "Polio Eradication or Comeback? Outcome Reporting Bias in the 1954 Poliomyelitis Vaccine Field Trial[v1] | Preprints.org")
Polio Eradication or Comeback? Outcome Reporting Bias in the 1954 Poliomyelitis Vaccine Field Trial[v1] | Preprints.org
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population | Nature Medicine
Absolute risk reduction formula vs. Relative risk reduction | wusa9.com
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection | Nature Medicine
Absolute Risk Reduction versus Relative Risk Reduction: Is One Better for COVID vaccines? - YouTube
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials - The Lancet Infectious Diseases
Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study | The BMJ
Medicina | Free Full-Text | Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine
Medicina | Free Full-Text | Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room - The Lancet Microbe
